Cellulitishttps://en.wikipedia.org/wiki/Cellulitis
Cellulitis cuta ce ta kwayan cuta da ta shafi sassan fata na ciki. A matsayin alamu da bayyanar cututtuka, yanki mai raɗaɗi na ja yana ƙaruwa cikin ƴan kwanaki. Iyakokin wurin jajayen gabaɗaya ba su da kyau sosai kuma fata na iya kumbura. Yankin kamuwa da cuta yawanci yana da zafi. Mutum na iya samun zazzabi da mygia.

Kafafu da fuska sune wuraren da aka fi yawan shiga ciki. Abubuwan haɗari sun haɗa da kiba, kumburin ƙafafu, da tsufa. Kwayoyin da aka fi sani da su sune streptococci da Staphylococcus aureus.

Magani yawanci ana shan maganin rigakafi da baki, kamar cephalexin, amoxicillin ko cloxacillin. Kusan kashi 95% na mutane sun fi kyau bayan kwanaki 7 zuwa 10 na jiyya. Wadanda ke da ciwon sukari, duk da haka, galibi suna samun sakamako mafi muni.

Cellulitis cuta ce ta kowa da kowa, kuma a cikin Burtaniya, cellulitis shine dalilin 1.6% na shiga asibiti. Cellulitis a cikin 2015 ya haifar da mutuwar kusan 16,900 a duk duniya.

Jiyya - Magungunan OTC
Ci gaban cellulitis yana buƙatar magani tare da maganin rigakafi wanda likita ya tsara kawai. Idan ciwon ya ci gaba da sauri kuma yana tare da zazzabi da sanyi, yana da kyau a ga likita da wuri-wuri.
Aiwatar da maganin maganin maganin maganin rigakafi ga raunukan farko na iya taimakawa. Idan an shafa man shafawa sosai, mai yiwuwa ba zai yi aiki da komai ba.
#Polysporin
#Bacitracin
#Betadine

Yi amfani da magungunan OTC kamar acetaminophen don rage zafi.
#Ibuprofen
#Naproxen
#Acetaminophen

Tsaftace ƙafafu da kuma kula da ƙafar 'yan wasa saboda ƙafar 'yan wasa na ƙara haɗarin cellulitis.

Magani
#First-generation cephalosporins (e.g. Cefradine)
#Bacterial culture
#Third-generation cephalosporins (e.g. Cefditoren Pivoxil)
☆ A cikin sakamakon Stiftung Warentest na 2022 daga Jamus, gamsuwar mabukaci tare da ModelDerm ya ɗan yi ƙasa kaɗan fiye da biyan shawarwarin telemedicine.
  • Ƙafafun wuri ne gama gari don Cellulitis.
  • Na al'ada
  • Cellulitis - matakin waraka
  • Cellulitis akan kafar hagu. Idan ya yadu sosai, zazzaɓi mai zafi zai iya faruwa, wanda zai haifar da girgiza mai haɗari mai haɗari.
  • Lokacin da raunin ya inganta, hyperpigmentation bayan kumburi na iya bayyana.
  • Yana iya zama sanadin rauni a tafin hannu.
  • Na al'ada
  • Idan facin erythematous mai taushi ya bazu cikin sauri, Cellulitis yakamata a yi zargin.
  • Kamar yadda Cellulitis ke inganta, matattun ƙwayoyin fata na iya barewa, kuma yana iya zama ƙaiƙayi.
  • Mafi yawan Cellulitis suna tare da kumburi da erythema a cikin kewaye. Duk da haka, a cikin wannan yanayi na musamman inda babu erythema da ke kewaye, ya kamata a yi zargin carcinoma na squamous cell.
  • Na al'ada
  • lokacin waraka.
References Cellulitis 31747177 
NIH
Cellulitis ciwon fata ne da ya zama ruwan dare. Yana shafar sama da mutane miliyan 14 a shekara a Amurka. Yana haifar da kusan dala biliyan 3. 7 a cikin farashin kulawar gaggawa da kuma asibitoci 650,000 kowace shekara. Yawanci, cellulitis yana nunawa azaman wuri mai dumi, ja akan fata tare da kumburi da taushi. Yana haifar da kamuwa da cuta kwatsam wanda ke haifar da kumburi a cikin zurfin fatar fata da nama na kusa. Babu ƙurji ko ƙurji da wannan kamuwa da cuta. Beta-hemolytic streptococci, musamman rukunin A streptococcus (Streptococcus pyogenes) , sune masu laifi na yau da kullun, sannan methicillin-sensitive Staphylococcus aureus.
Cellulitis is a common bacterial skin infection, with over 14 million cases occurring in the United States annually. It accounts for approximately 3.7 billion dollars in ambulatory care costs and 650000 hospitalizations annually. Cellulitis typically presents as a poorly demarcated, warm, erythematous area with associated edema and tenderness to palpation. It is an acute bacterial infection causing inflammation of the deep dermis and surrounding subcutaneous tissue. The infection is without an abscess or purulent discharge. Beta-hemolytic streptococci typically cause cellulitis, generally group A streptococcus (i.e., Streptococcus pyogenes), followed by methicillin-sensitive Staphylococcus aureus. Patients who are immunocompromised, colonized with methicillin-resistant Staphylococcus aureus, bitten by animals, or have comorbidities such as diabetes mellitus may become infected with other bacteria.
 Cellulitis: current insights into pathophysiology and clinical management 29219814
Cellulitis cuta ce ta kwayoyin cuta daga fata da laushin kyallen takarda. Yana faruwa a lokacin da akwai matsala tare da shingen kariya na fata, tsarin rigakafi, ko zagayawa na jini. Ciwon sukari, kiba, da tsufa suna ƙara haɗarin cellulitis ta hanyar shafar waɗannan wuraren. Har ila yau, muna duban binciken da aka yi a kwanan nan game da gano cellulitis , yana nuna mahimmancin mahimmancin ganewar asali tun da yanayi kamar rashin isasshen jini, eczema, thrombosis mai zurfi, da gout suna yawan rikicewa tare da cellulitis. Ana zaɓar maganin rigakafi da ake amfani da su don magance cellulitis a hankali don kai hari ga ƙwayoyin cuta na yau da kullun ba tare da ƙarfafa juriya na ƙwayoyin cuta ba. Muna kuma magana game da sababbin maganin rigakafi da aka amince da su don cellulitis. Cellulitis sau da yawa yakan dawo saboda abubuwan haɗari masu gudana da lalacewa ga tsarin lymphatic.
Cellulitis is a bacterial infection of the skin and soft tissues. It happens when there are issues with the skin's protective barrier, the immune system, or blood circulation. Diabetes, obesity, and old age increase the chances of cellulitis by affecting these areas. We also look at recent findings on diagnosing cellulitis, highlighting the importance of accurate diagnosis since conditions like venous insufficiency, eczema, deep vein thrombosis, and gout are often confused with cellulitis. Antibiotics used to treat cellulitis are chosen carefully to target common bacteria without encouraging antibiotic resistance. We also talk about new antibiotics approved for cellulitis. Cellulitis often comes back because of ongoing risk factors and damage to the lymphatic system..
 Current Treatment Options for Acute Skin and Skin-structure Infections 30957166 
NIH
Mutane da yawa suna zuwa asibitoci ko dakunan gaggawa don kamuwa da cututtukan fata kwatsam. Staphylococcus aureus shine babban kwayar cutar da ke haifar da wadannan cututtuka, kuma yana da wuyar magancewa saboda wasu nau'o'in suna da maganin rigakafi.
Acute bacterial skin and skin-structure infections are a common reason for seeking care at acute healthcare facilities, including emergency departments. Staphylococcus aureus is the most common organism associated with these infections, and the emergence of community-associated methicillin-resistant Staphylococcus aureus (MRSA) has represented a considerable challenge in their treatment.
 Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus 32257966 
NIH
Za a iya raba Staphylococcus aureus zuwa nau'i biyu bisa la'akari da martaninsu ga maganin rigakafi: methicillin-sensitive Staphylococcus aureus (MSSA) , methicillin-resistant Staphylococcus aureus (MRSA) . A cikin 'yan shekarun da suka gabata, saboda juyin halittar kwayan cuta da kuma yawan amfani da maganin rigakafi, juriyar S. Aureus ga magunguna na karuwa, wanda ke haifar da karuwar duniya a MRSA adadin kamuwa da cuta.
According to the sensitivity to antibiotic drugs, S. aureus can be divided into methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA). In recent decades, due to the evolution of bacteria and the abuse of antibiotics, the drug resistance of S. aureus has gradually increased, the infection rate of MRSA has increased worldwide.
 Treatment of severe skin and soft tissue infections: a review 29278528 
NIH
To review the salient features of the management of severe skin and soft tissue infections (SSTIs), including toxic shock syndrome, myonecrosis/gas gangrene, and necrotizing fasciitis.